Table 2.
Grad-CAM Saliency Map Analysis
| Region | Receiving Glaucoma Medication | Not Receiving Glaucoma Medication | P |
|---|---|---|---|
| 1 | 35.0% | 45.0% | 0.19 |
| 2 | 55.0% | 56.0% | 1.00 |
| 3 | 75.0% | 47.0% | < 0.01a |
Region 1 was comprised of the central anterior segment, including the cornea and iris; region 2, perilimbal area including the conjunctiva, sclera, and associated vasculature; and region 3, periocular area, primarily involving the upper and lower eyelids.
a
Statistically significant (P < 0.05). Fisher's exact test was used for the analyses.